新一代冠状病毒病2019疫苗:临床数据和未来方向。

IF 6.1 3区 医学 Q1 IMMUNOLOGY
Kathryn E. Stephenson MD, MPH
{"title":"新一代冠状病毒病2019疫苗:临床数据和未来方向。","authors":"Kathryn E. Stephenson MD, MPH","doi":"10.1016/j.idc.2025.02.003","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13562,"journal":{"name":"Infectious disease clinics of North America","volume":"39 2","pages":"Pages 253-274"},"PeriodicalIF":6.1000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Next-Generation Coronavirus Disease 2019 Vaccines\",\"authors\":\"Kathryn E. Stephenson MD, MPH\",\"doi\":\"10.1016/j.idc.2025.02.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13562,\"journal\":{\"name\":\"Infectious disease clinics of North America\",\"volume\":\"39 2\",\"pages\":\"Pages 253-274\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2025-03-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious disease clinics of North America\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S089155202500008X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious disease clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S089155202500008X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

自2019冠状病毒病(COVID-19)大流行开始以来,目前的疫苗已防止数百万人死亡。然而,目前的疫苗存在严重的局限性:(1)它们引起的粘膜免疫反应较差,对感染和病毒传播的保护作用降低;(2)免疫反应迅速减弱;(3)新的免疫逃避性严重急性呼吸综合征冠状病毒2变体不断出现。下一代疫苗旨在通过粘膜给药诱导粘膜免疫改善,并通过自我扩增RNA等新平台诱导更长的免疫反应持续时间和广度。本综述的重点是具有公开临床数据且最有可能继续进一步开发的下一代COVID-19疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Next-Generation Coronavirus Disease 2019 Vaccines
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.30
自引率
0.00%
发文量
75
审稿时长
6-12 weeks
期刊介绍: Infectious Disease Clinics of North America updates you on the latest trends in the clinical diagnosis and management of patients with infectious diseases, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in infectious disease, including clinical microbiology, compromised host infections, gastrointestinal infections, global health, hepatitis, HIV/AIDS, hospital-acquired infections, travel medicine, infection control, bacterial infections, sexually transmitted diseases, urinary tract infections, and viral infections.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信